Bill Snyder Archive — Page 51 of 119
-
February 6, 2020
Conn, Calipari to receive major pharmacology awards
Two Vanderbilt University pharmacologists have won prestigious awards from the American Society for Pharmacology and Experimental Therapeutics (ASPET). -
February 6, 2020
Carnahan named associate director of Vaccine Center
Robert Carnahan, PhD, associate professor of Pediatrics and Radiology and Radiological Sciences, has been appointed associate director of the Vanderbilt Vaccine Center. -
February 6, 2020
Genetics and EHRs
Lisa Bastarache, MS, research assistant professor of Biomedical Informatics, and Tony Capra, PhD, associate professor of Biological Sciences and Biomedical Informatics, described the intersection of genetics and electronic health records during last week’s Cutting-Edge Discovery Lecture. -
February 6, 2020
Team tracks integrin’s role in lung function
Beta-1 integrin, a critical component of epithelial extracellular matrix receptors, is essential for normal lung function in adulthood, researchers at VUMC have discovered. -
February 6, 2020
Nobel Prize-winning biochemist Stanley Cohen dies at 97
Vanderbilt University biochemist Stanley Cohen, PhD, whose discovery of epidermal growth factor (EGF) and its receptor earned him a Nobel Prize and opened the door to a new class of cancer therapies, died Wednesday, Feb. 5, in Nashville. He was 97. -
February 5, 2020
Vaccine Program receives NIH renewal of VTEU
The Vanderbilt Vaccine Research Program has received a grant from the NIH to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units.